Location History:
- Takatsuki, JA (1976)
- Osaka, JP (1980 - 1985)
- Ibaraki, JP (1981 - 1989)
- Kobe, JP (1988 - 1995)
Company Filing History:
7 out of 6,896 
6 out of 174 
1 out of 329 Years Active: 1976-1995
Title: Yoshiya Yamahira: Innovator in Sustained-Release Technologies
Introduction
Yoshiya Yamahira is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release injection technologies. With a total of 13 patents to his name, Yamahira's work has had a lasting impact on drug delivery systems.
Latest Patents
Yamahira's latest patents include innovative formulations for sustained-release injections. One notable invention is a sustained-release injection that comprises a suspension of a powder containing an active ingredient and a biodegradable carrier. This carrier can include proteins, polysaccharides, and synthetic high molecular compounds, such as collagen and gelatin. The injection is designed to release the active ingredient at an effective level over an extended period. Another significant patent is a sustained-release preparation of indomethacin or interferon, which utilizes a biodegradable carrier, particularly collagen or gelatin. This preparation is especially suitable for parenteral administration and ensures a prolonged release of the active ingredient.
Career Highlights
Throughout his career, Yoshiya Yamahira has worked with notable companies, including Sumitomo Chemical Company, Limited and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the advancement of drug delivery systems.
Collaborations
Yamahira has collaborated with esteemed colleagues, including Keiji Fujioka and Shigeji Sato. These partnerships have fostered a collaborative environment that has led to the development of groundbreaking technologies in the pharmaceutical industry.
Conclusion
Yoshiya Yamahira's contributions to sustained-release technologies have positioned him as a key figure in the pharmaceutical field. His innovative patents and collaborations reflect his commitment to improving drug delivery systems. His work continues to influence the industry and enhance patient care through effective medication administration.